期刊文献+

老年重症药疹33例临床分析 被引量:4

Analysis of 33 Cases of Aged People With Severe Drug Eruption
下载PDF
导出
摘要 目的探讨老年重症药疹患者的临床特点。方法对本院2000年1月~2007年12月收治的33例老年重症药疹患者的临床资料进行回顾性分析。结果重症多形红斑型药疹所占比例最高,为48.48%;重症药疹中致敏药物以别嘌呤醇占首位,为32.26%;伴有基础疾病患者的皮疹控制时间及住院天数均较无基础疾病患者长(t值分别为2.377,2.160,P均<0.05),有肝功损害的患者糖皮质激素起始用量大于无肝功能损害的患者(t=2.278,P<0.05)。结论糖皮质激素起始治疗量与重症药疹类型、是否伴有肝脏损害关系密切;皮疹的控制时间及住院天数与是否合并基础疾病有关。 Objective To investigate the clinical features of aged people with severe drug eruption. Methods To analyze the clinical data of 33 aged people with severe drug eruption in our hospital during January 2000 to December 2007. Results SJS accounted for the highest proportion. Opurinol was the commonest initiating drug. The rash - controlled duration and length of hospitalization in inpatients with basis disease were longer than those without it. Dose of initial glucocorticoid in patients who had liver damage was larger than those with no liver damage. Conclusion Does of initial glucocorticoid was correlated both the type of severe drug eruption and liver damage. The rash -controlled duration was correlated with whether there was basis disease.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2009年第2期90-91,共2页 The Chinese Journal of Dermatovenereology
关键词 老年 重症药疹 分析 Aged people Severe drug eruption Analysis
  • 相关文献

参考文献5

二级参考文献27

共引文献58

同被引文献18

  • 1李佳玟,郭毓文,王俐.重型药疹55例临床分析[J].中国麻风皮肤病杂志,2004,20(4):356-356. 被引量:6
  • 2张峰,金会文,周毅成,李鹤玉,郑淑云,孙丽梅,刘惠瑜,刘会彬.大疱性表皮松解型药疹的临床分析[J].中华皮肤科杂志,2006,39(6):364-364. 被引量:8
  • 3何志新,甘戈,王宝玺.539例药疹临床分析[J].中华皮肤科杂志,2006,39(12):703-705. 被引量:40
  • 4马川,李邻峰.45例重症药疹患者发病情况分析[J].中国麻风皮肤病杂志,2007,23(1):37-39. 被引量:12
  • 5刘京平,林有坤.住院儿童药疹38例临床分析[J].广西医科大学学报,2007,24(3):432-433. 被引量:1
  • 6张学军.皮肤病学[M].6版.北京:人民卫生出版社,2005:113-114.
  • 7Huang HY,Luo XQ,Chan LS,et al. Cutaneous ad- verse drug reactions in a hospital-based Chinese population[J]. Clin Exp Dermatol,2010,35(6) :1-6.
  • 8Sushma M, Noel MV, Ritika MC, et al. Cutaneous adverse drug reactions:a 9 year study from a South Indian Hospital[J]. Pharmacoepidemiol Drug Saf, 2005,14(8) : 567-570.
  • 9Ozeki T, Mushiroda T, Yowang A, et al. Genome- wide association study identifies HLA A * 3101 al- lele as a genetic risk factor for carbamazepine-in- duced cutaneous adverse drug reactions in Japanese population[J]. Hum Mol Genet, 2011,20 ( 5 ) : 1034- 1041.
  • 10Wu XT,Hu FY,An DM,et al. Association between carbamazepine-induced cutaneous adverse drug reac- tions and the HLA-B * 1502 allele among patients in central China[J]. Epilepsy Behav, 2010,19 (3): 405- 408.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部